Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

IDOXURIDINE CRS (50 MG)

IDOXURIDINE CRS (50 MG)

54-42-2

DISCOVER
IFOSFAMIDE CRS (50 MG)

IFOSFAMIDE CRS (50 MG)

3778-73-2

DISCOVER
IFOSFAMIDE IMPURITY A CRS (100 MG)

IFOSFAMIDE IMPURITY A CRS (100 MG)

NA

DISCOVER
IFOSFAMIDE IMPURITY B CRS (40MG)

IFOSFAMIDE IMPURITY B CRS (40MG)

NA

DISCOVER
IFOSFAMIDE IMPURITY E CRS (40MG)

IFOSFAMIDE IMPURITY E CRS (40MG)

NA

DISCOVER
IFOSFAMIDE IMPURITY F CRS (15MG)

IFOSFAMIDE IMPURITY F CRS (15MG)

40722-73-4

DISCOVER
IFOSFAMIDE - REFERENCE SPECTRUM (N/A)

IFOSFAMIDE - REFERENCE SPECTRUM (N/A)

NA

DISCOVER
IMIDAZOLE CRS (60 MG)

IMIDAZOLE CRS (60 MG)

288-32-4

DISCOVER
IMIPENEM CRS (70 MG)

IMIPENEM CRS (70 MG)

74431-23-5

DISCOVER
IMIPRAMINE HYDROCHLORIDE CRS (50 MG)

IMIPRAMINE HYDROCHLORIDE CRS (50 MG)

113-52-0

DISCOVER
INDAPAMIDE CRS (150 MG)

INDAPAMIDE CRS (150 MG)

26807-65-8

DISCOVER
INDAPAMIDE IMPURITY B CRS (15MG)

INDAPAMIDE IMPURITY B CRS (15MG)

63968-75-2

DISCOVER